中国实用妇科与产科杂志2026,Vol.42Issue(4):389-395,7.DOI:10.19538/j.fk2026040102
产房中缩宫素应用的精细化管理与风险管控
Refined management and risk control in the use of oxytocin in delivery rooms
摘要
Abstract
Oxytocin plays a crucial role in the process of labor induction and augmentation by promoting uterine contractions.However,its administration requires refined management to ensure maternal and fetal safety and to avoid uterine tachysystole and related complications.This article systematically reviews the physiological and pharmacological mechanisms of oxytocin,clinical outcomes of different administration protocols,monitoring techniques,risk factors and corresponding control strategies.Incorporating the latest randomized controlled trials and observational studies,it focuses on the clinical value of oxytocin dose adjustment,timing of use,individualized management,and multidisciplinary collaboration in reducing cesarean section rates and preventing uterine rupture and postpartum hemorrhage.Through a comprehensive analysis of existing evidence,this paper aims to provide evidence-based guidance for clinical obstetric practice,promote the safe and effective use of oxytocin,optimize delivery room management protocols,and improve maternal and neonatal health outcomes.关键词
缩宫素/产房管理/风险管控/剖宫产/子宫破裂/产后出血Key words
oxytocin/delivery room management/risk control/cesarean section/uterine rupture/postpartum hemorrhage分类
医药卫生引用本文复制引用
金志珊,赵茵..产房中缩宫素应用的精细化管理与风险管控[J].中国实用妇科与产科杂志,2026,42(4):389-395,7.基金项目
National Natural Science Foundation of China(82171678) (82171678)
Shenzhen Basic Research Special Project(Natural Science Foundation)(JCYJ20230807143504009) 国家自然科学基金(82171678) (Natural Science Foundation)
深圳市基础研究专项(自然科学基金)(JCYJ20230807143504009) (自然科学基金)